Synthesis and characterization of collagen/hydroxyapatite: Magnetite composite material for bone cancer treatment

Journal of Materials Science: Materials in Medicine

Volumn 21, Issue 7, 2010, Pages 2237-2242

  Andronescu, Ecaterina ^a   Ficai, Maria ^a   Voicu, Georgeta ^a   Ficai, Denisa ^a   Maganu, Maria ^b   Ficai, Anton ^a  

^a UNIVERSITY POLITEHNICA OF BUCHAREST   (Romania)

^b INSTITUTE OF ORGANIC CHEMISTRY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

BONE CANCER; BONE GRAFT; BONE GRAFT MATERIALS; COMPLEX COMPOSITE SYSTEMS; COPRECIPITATION METHOD; FTIR; SEM; SYNTHESIS AND CHARACTERIZATION; TEMPERATURE INCREASE; TUMORAL CELLS; XRD;

BONE; CELL DEATH; COMPOSITE MATERIALS; COMPOSITE MICROMECHANICS; ELECTROMAGNETIC FIELDS; GRAFTING (CHEMICAL); MAGNETITE; OXIDE MINERALS; PRECIPITATION (CHEMICAL);

HYPERTHERMIA THERAPY;

COLLAGEN; HYDROXYAPATITE; MAGNETITE;

APOPTOSIS; ARTICLE; BONE CANCER; BONE GRAFT; CANCER THERAPY; COMPOSITE MATERIAL; ELECTROMAGNETIC FIELD; HYPERTHERMIC THERAPY; PRIORITY JOURNAL; SYNTHESIS; TUMOR CELL;

BONE AND BONES; BONE NEOPLASMS; BONE TRANSPLANTATION; CALCIUM METABOLISM DISORDERS; COLLAGEN; DURAPATITE; EXTRACELLULAR MATRIX; FERROSOFERRIC OXIDE;

EID: 77954481625     PISSN: 09574530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10856-010-4076-7     Document Type: Article

References (27)

1. M Brahler R Georgieva N Buske A Muller S Muller J Pinkernelle, et al. 2006 Magnetite-loaded carrier erythrocytes as contrast agents for magnetic resonance imaging Nano Lett 6 11 2505 2509 10.1021/nl0618501 1:STN:280:DC%2BD28nos1Gmtg%3D%3D 17090081 2006NanoL...6.2505B (Pubitemid 46076940)
2. CY Lin KC Ho 2007 Synthesis of superparamagnetic magnetite nanoparticles for thermoresponsive drug delivery Nanotechnology 2 405 408 1:CAS:528: DC%2BD1MXht1Sitbw%3D
3. J Yang H Lee W Hyung S-B Park S Haam 2006 Magnetic PECA nanoparticles as drug carriers for targeted delivery: synthesis and release characteristics J Microencapsul 23 2 203 212 10.1080/02652040500435444 1:CAS:528: DC%2BD28XmvVagt7w%3D 16754376 (Pubitemid 43840671)
4. F Matsuoka M Shinkai H Honda T Kubo T Sugita T Kobayashi 2004 Hyperthermia using magnetite cationic liposomes for hamster osteosarcoma Biomagn Res Technol 2 1 3 10.1186/1477-044X-2-3 15040804
5. Orentas R, Hodge JW, Johnson BD, editors. Cancer vaccines and tumor immunity. New York: Wiley; 2008.
6. BQ Li DC Jia Y Zhou QL Hu W Cai 2007 Magnetic hydroxyapatite/chitosan nanocomposites via in situ hybridization strategy Bioceramics 330-332 Pts 1-2 357 360
7. J Wu QL Hu FP Chen BQ Li JC Shen 2007 Study of the mechanical property of magnetite/hydroxyapatite/chitosan nano-composite Bioceramics 330-332 Pts 1-2 435 438
8. W Cui QL Hu J Wu BQ Li JC Shen 2008 Preparation and characterization of magnetite/hydroxyapatite/chitosan nanocomposite by in situ compositing method J Appl Polym Sci 109 4 2081 2088 10.1002/app.28013 1:CAS:528:DC%2BD1cXnsl2gtr8%3D
9. S Murakami T Hosono B Jeyadevan M Kamitakahara K Ioku 2008 Hydrothermal synthesis of magnetite/hydroxyapatite composite material for hyperthermia therapy for bone cancer J Ceram Soc Jpn 116 1357 950 954 10.2109/jcersj2.116.950 1:CAS:528:DC%2BD1cXhtFalsrrP
10. E Ruel-Gariepy M Shive A Bichara M Berrada D Le Garrec A Chenite, et al. 2004 A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel Eur J Pharm Biopharm 57 1 53 63 10.1016/S0939-6411(03)00095-X 1:CAS:528:DC%2BD2cXjsFaksw%3D%3D 14729080 (Pubitemid 38058803)
11. XL Yan RA Gemeinhart 2005 Cisplatin delivery from poly(acrylic acid-co-methyl methacrylate) microparticles J Control Release 106 1-2 198 208 10.1016/j.jconrel.2005.05.005 1:CAS:528:DC%2BD2MXntlShsr4%3D 15979187 (Pubitemid 41149078)
12. HT Ta CR Dass DE Dunstan 2008 Injectable chitosan hydrogels for localised cancer therapy J Control Release 126 3 205 216 10.1016/j.jconrel.2007.11.018 1:CAS:528:DC%2BD1cXis1amsL4%3D 18258328
13. LH Reddy RK Sharma K Chuttani AK Mishra RSR Murthy 2005 Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice J Control Release 105 3 185 198 10.1016/j.jconrel.2005.02.028 1:CAS:528: DC%2BD2MXlvVyrsbY%3D (Pubitemid 40941985)
14. T Miyazaki C Yomota S Okada 2001 Development and release characterization of hyaluronan-doxycycline gels based on metal coordination J Control Release 76 3 337 347 10.1016/S0168-3659(01)00453-9 1:CAS:528:DC%2BD3MXntVWktr4%3D 11578747 (Pubitemid 32913441)
15. M Konishi Y Tabata M Kariya H Hosseinkhani A Suzuki K Fukuhara, et al. 2005 In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel J Control Release 103 1 7 19 10.1016/j.jconrel. 2004.11.014 1:CAS:528:DC%2BD2MXhtlequr8%3D 15710496 (Pubitemid 40248557)
16. JH Kim YS Kim K Park S Lee HY Nam KH Min, et al. 2008 Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice J Control Release 127 1 41 49 10.1016/j.jconrel.2007.12.014 1:CAS:528: DC%2BD1cXjt12qsrc%3D 18234388
17. H Harashima S Iida Y Urakami M Tsuchihashi H Kiwada 1999 Optimization of anti-tumor effect of liposomally encapsulated doxorubicin based on simulations by pharmacokinetic/pharmacodynamic modeling J Control Release 61 1-2 93 106 10.1016/S0168-3659(99)00110-8 1:CAS:528:DyaK1MXlsFOku7g%3D 10469906 (Pubitemid 29406083)
18. S Cafaggi E Russo R Stefani R Leardi G Caviglioli B Parodi, et al. 2007 Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex J Control Release 121 1-2 110 123 10.1016/j.jconrel.2007.05.037 1:CAS:528:DC%2BD2sXosFelu7c%3D 17601625 (Pubitemid 47161043)
19. JP Wang K Takayama T Nagai Y Maitani 2003 Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterol Int J Pharm 251 1-2 13 21 1:CAS:528: DC%2BD3sXis1Whsw%3D%3D
20. DJA Netz P Sepulveda VC Pandolfelli ACC Spadaro JB Alencastre MVLB Bentley, et al. 2001 Potential use of gelcasting hydroxyapatite porous ceramic as an implantable drug delivery system Int J Pharm 213 1-2 117 125 10.1016/S0378-5173(00)00659-1 1:CAS:528:DC%2BD3MXmvFKqtw%3D%3D 11165099 (Pubitemid 32119467)
21. R Xu J Ma XC Sun ZP Chen XL Jiang ZR Guo, et al. 2009 Ag nanoparticles sensitize IR-induced killing of cancer cells Cell Res 19 8 1031 1034 10.1038/cr.2009.89 1:CAS:528:DC%2BD1MXpsFyqtLo%3D 19621033
22. OV Melnikov OY Gorbenko MN Markelova AR Kaul VA Atsarkin VV Demidov, et al. 2009 Ag-doped manganite nanoparticles: new materials for temperature-controlled medical hyperthermia J Biomed Mater Res A 91A 4 1048 1055 10.1002/jbm.a.32177 1:CAS:528:DC%2BD1MXhtl2rtr%2FJ
23. GF Paciotti L Myer D Weinreich D Goia N Pavel RE McLaughlin, et al. 2004 Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery Drug Deliv 11 3 169 183 10.1080/10717540490433895 1:CAS:528:DC%2BD2cXks1aiurc%3D 15204636 (Pubitemid 38720414)
24. A Ficai E Andronescu C Ghitulica G Voicu V Trandafir D Manzu, et al. 2009 Collagen/hydroxyapatite interactions in composite biomaterials Mater Plast 46 1 11 15 1:CAS:528:DC%2BD1MXmtV2jtrY%3D
25. Y Li A Asadi MR Monroe EP Douglas 2009 pH effects on collagen fibrillogenesis in vitro: electrostatic interactions and phosphate binding Mater Sci Eng C 29 5 1643 1649 10.1016/j.msec.2009.01.001 1:CAS:528: DC%2BD1MXmtVaqsrk%3D
26. A Ficai E Andronescu G Voicu C Ghitulica D Ficai 2010 The influence of collagen support and ionic species on the morphology of collagen/hydroxyapatite composite materials Mater Charact 61 402 407 10.1016/j.matchar.2010.01.003 10.1016/j.matchar.2010.01.003 1:CAS:528:DC%2BC3cXjsF2hs7k%3D
27. A Ficai E Andronescu V Trandafir C Ghitulica G Voicu 2010 Collagen/hydroxyapatite composite obtained by electric field orientation Mater Lett 64 4 541 544 10.1016/j.matlet.2009.11.070 1:CAS:528:DC%2BC3cXht1ejsg%3D%3D